3.0 Tesla MR Spectroscopy for the assessment of hepatic steatosis in severely obese patients before and after weight reduction

3.0 Tesla MR Spectroscopy for the assessment of hepatic steatosis in severely obese patients before and after weight reduction - MR Spectroscopy for the assessment of hepatic steatosis in obese patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30836

Enrollment

Registered

2007-10-25

Start date

2008-10-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver non-alcoholic fatty liver disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients over 18 years of age Patients who will undergo bariatric surgery for weight reduction at the Rijnstate hospital in Arnhem

Exclusion criteria

Exclusion criteria: Patients with extreme obesity (maximum weight limit MRI scanner 150kg, diameter 60 cm) Patients under 18 years of age Patients who are pregnant Patients who are claustrophobic Patients who have magnetic or radiofrequency sensitive implants

Design outcomes

Primary

Measure	Time frame
Assessment of hepatic steatosis with 3.0 Tesla MR Spectroscopy in severely obese patients before and after weight reduction established by bariatric surgery and its correlation with clinical parameters and blood tests	—

Secondary

Measure	Time frame
Assessment of hepatic steatosis with 3.0 Tesla MR Spectroscopy in severely obese patients before and after weight reduction established by bariatric surgery and its correlation with clinical parameters and blood tests	—

Countries

Netherlands

Outcome results